U.S. flag

An official website of the United States government

GRCh37/hg19 Xq28(chrX:153575641-153645284)x2 AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jan 21, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002291536.3

Allele description [Variation Report for GRCh37/hg19 Xq28(chrX:153575641-153645284)x2]

GRCh37/hg19 Xq28(chrX:153575641-153645284)x2

Genes:
DNASE1L1:deoxyribonuclease 1 like 1 [Gene - OMIM - HGNC]
EMD:emerin [Gene - OMIM - HGNC]
FLNA:filamin A [Gene - OMIM - HGNC]
RPL10:ribosomal protein L10 [Gene - OMIM - HGNC]
TAFAZZIN:tafazzin, phospholipid-lysophospholipid transacylase [Gene - OMIM - HGNC]
Variant type:
copy number gain
Cytogenetic location:
Xq28
Genomic location:
ChrX: 153575641 - 153645284 (on Assembly GRCh37)
Preferred name:
GRCh37/hg19 Xq28(chrX:153575641-153645284)x2
HGVS:

    Condition(s)

    Synonyms:
    none provided
    Identifiers:
    MedGen: CN517202

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...

    Assertion and evidence details

    Submission AccessionSubmitterReview Status
    (Assertion method)
    Clinical Significance
    (Last evaluated)
    OriginMethodCitations
    SCV002583855Illumina Laboratory Services, Illumina
    criteria provided, single submitter

    (ICSL CNVClassificationCriteria Aug2020)
    Uncertain significance
    (Jan 21, 2022)
    unknownclinical testing

    PubMed (5)
    [See all records that cite these PMIDs]

    Citation Link

    Summary from all submissions

    EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
    not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

    Citations

    PubMed

    X-chromosome tiling path array detection of copy number variants in patients with chromosome X-linked mental retardation.

    Madrigal I, Rodríguez-Revenga L, Armengol L, González E, Rodriguez B, Badenas C, Sánchez A, Martínez F, Guitart M, Fernández I, Arranz JA, Tejada M, Pérez-Jurado LA, Estivill X, Milà M.

    BMC Genomics. 2007 Nov 29;8:443.

    PubMed [citation]
    PMID:
    18047645
    PMCID:
    PMC2234261

    Xq28 duplication presenting with intestinal and bladder dysfunction and a distinctive facial appearance.

    Clayton-Smith J, Walters S, Hobson E, Burkitt-Wright E, Smith R, Toutain A, Amiel J, Lyonnet S, Mansour S, Fitzpatrick D, Ciccone R, Ricca I, Zuffardi O, Donnai D.

    Eur J Hum Genet. 2009 Apr;17(4):434-43. doi: 10.1038/ejhg.2008.192. Epub 2008 Oct 15.

    PubMed [citation]
    PMID:
    18854860
    PMCID:
    PMC2986219
    See all PubMed Citations (5)

    Details of each submission

    From Illumina Laboratory Services, Illumina, SCV002583855.1

    #EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
    1not providednot providednot providednot providedclinical testing PubMed (5)

    Description

    This CNV is 35 kb and 17 kb duplication of Xq28 on chromosome X, (seq[GRCh37]dup(X)(q28); chr9:g.((153575641_ 153610949)_(153642662_ 153645284)dup), which is inherited. The breakpoints are uncertain due to current technological limitations. This CNV constitutes a duplication encompassing five protein coding genes, including FLNA, EMD, DNASE1L1, RPL10, and TAZ, and is in the region of the well-described Xq28 microduplication syndrome, though the causative genes associated with this microduplication syndrome are not found in this duplication (Vandewalle et al. 2009; Ballout et al. 2020). Patients with duplications similar in size and genomic content to this duplication have not been reported in the peer-reviewed literature. Several patients with partially overlapping duplications are reported, with phenotypes including global intellectual disability, periventricular nodular heterotopia, pseudo-obstruction, malrotation, dilated bowels, seizures, non-ambulation, delayed speech, psychomotor delay, poor coordination, dysmorphic features, microcephaly, cardiac abnormalities, behavioral issues, and thrombocytopenia (Madrigal et al. 2007; Clayton-Smith et al. 2009; Firth et al. 2009; Kong et al. 2021). Based on the available evidence, this CNV is classified as a variant of uncertain significance.

    #SampleMethodObservation
    OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
    1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

    Last Updated: Apr 9, 2023